ArticleNPJ precision oncology2025

Venetoclax resistance in preclinical KMT2A-rearranged acute lymphoblastic leukemia models is characterized by high inter- and intra-model heterogeneity.

Anna Richter et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.